Skip to content

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With NAFLD

Effect of Multi Vitamin and Mineral Supplementation of Liver Enzymes and Sonography in Patient With Non-alcoholic Fatty Disease (NAFLD); RCR

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05897606
Enrollment
160
Registered
2023-06-09
Start date
2023-02-01
Completion date
2023-05-03
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Alcoholic Fatty Liver Disease

Brief summary

The study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD

Detailed description

This study was performed on 160 participants, to ensure the impact of multi vitamin and mineral to reduce NAFLD. Participants were randomly selected to participate in the study. Then divided into the groups (intervention and placebo). Intervention received supplementation for 12 weeks and placebo received same capsule was made for placebo groups.

Interventions

COMBINATION_PRODUCTMultiviamins and minerals

The intervention group received one capsule of multivitamin and minerals supplements every day, one hour after breakfast, for 12 weeks.

COMBINATION_PRODUCTPlacebo

Placebo

Sponsors

Sulaimany Polytechnic university
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Intervention group received multivitamin and minerral

Eligibility

Sex/Gender
ALL
Age
22 Years to 78 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants with NAFLD diagnosed

Exclusion criteria

* subjects who in the last 6 months received vitamin or mineral supplementation, those with chronic conditions such as diabetes, hypertension, and heart disease, unwillingness to continue the study protocol, lactating women and pregnant women.

Design outcomes

Primary

MeasureTime frameDescription
Multivitamin and minerals supplementation has role in reduce liver enzymes12 weeksMultivitamin and minerals supplement was given for 12 weeks and has role in reduce Serum Bilirubin, alkaline phosphatase (ALP), alanine transaminase (ALT), and liver enzyme was measured by blood sampling tests.

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026